Michael J. Ross

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ross_Michael_MD_420x504.jpg

First Name

Michael

Last Name

Ross

NPI

1851321368

Faculty ID

15329

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="p1">&nbsp;</p>
<p class="p1">The major focus of research in the Ross laboratory is to identify novel mechanisms of kidney injury occurring in HIV-positive persons and his laboratory uses in vitro and murine models to generate new strategies to prevent and treat kidney diseases. Dr. Ross also works with members of the International Network for Strategic Initiatives in Global HIV Treatment (INSIGHT) to perform research on kidney disease in the context of large international HIV treatment trials.</p>
<p class="p1"><strong><span style="text-decoration: underline;">Ongoing NIH-funded projects:</span></strong></p>
<p class="p1"><strong>Mechanisms by which antiretroviral medications protect kidneys from HIV-induced injury:</strong></p>
<p class="p1">Though combination antiretroviral therapy (cART) is efficacious in preventing and treating HIV-associated nephropathy (HIVAN), the mechanisms by which these medications protect the kidney from the deleterious effects of HIV are poorly understood.&nbsp;&nbsp;We are performing studies using transgenic animal models and molecular and genomic techniques to identify novel pathways by which ART protect the kidneys from HIV.&nbsp;&nbsp;Moreover, we have exciting data suggesting that these medications may protect kidneys from non-viral mediated forms of kidney injury, including diabetic kidney disease.</p>
<p class="p1"><strong>The role of APOL1 polymorphisms in promoting HIV-induced kidney injury:</strong></p>
<p class="p1">Polymorphisms in the APOL1 gene account for most of the excess risk of African-Americans to non-diabetic kidney disease and HIV-associated kidney disease in particular. In our studies, we are using genetically modified human kidney cells to perform innovative proteomic, and genomic studies to identify novel mechanisms by APOL1 genetic variants predispose to HIV-induced kidney injury.&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p><span style="color:black;">Chronic kidney disease, diabetic kidney disease, acute kidney injury, glomerular diseases, cystic kidney diseases, electrolyte disorders, hypertension, HIV and other virus-related kidney diseases.</span></p>

Research Focus

<p><span style="color:black;">The primary focus of Dr. Ross' research is to identify mechanisms by which HIV and immune dysregulation cause kidney disease and to identify new approaches to prevent and treat kidney disease. Dr. Ross is also involved in clinical studies to determine mechanisms of diabetic kidney injury and to test the effectiveness of novel treatments for chronic kidney diseases.</span></p>

Elsevier Profile

Selected Publications

<p><span style="text-decoration: underline;"><strong>Most relevant publicatiion in past 10 years:</strong></span></p>
<p>*Mocroft, A., Wyatt, C., Szczech, L., Neuhaus, J., El-Sadr, W., Tracy, R., Kuller, L., Shlipak, M., Angus, B., Klinker, H., and <strong><span style="text-decoration: underline;">Ross, MJ</span></strong>. Interruption of antiretroviral therapy is associated with increased plasma cystatin C: Results from the SMART Study. <em>AIDS</em>. 23, 71-82. 2009.</p>
<p>*Snyder A, Alsauskas Z, Gong P, Rosenstiel P, Klotman M, Klotman P, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>: FAT10: a novel mediator of Vpr-induced apoptosis in HIV-associated nephropathy. <em>J Virol</em>. 83;11983-11988. 2009.</p>
<p>*Gong, P., Canaan, A., Wang, B., Leventhal, S., Snyder, A., Nair, V., Cohen, C. D., Kretzler, M., D'Agati, V., Weissman, S., and <strong><span style="text-decoration: underline;">Ross, M. J</span></strong>. The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol. 21:316. 2009.</p>
<p>Snyder A, Alsauskas ZC, Leventhal JS, Rosenstiel PE, Gong P, Chan J, Barley K, He C, Klotman M, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Klotman PE. HIV-1 viral protein r induces ERK and caspase-8 dependent apoptosis in renal tubular epithelial cells. <em>AIDS</em>, 24:1107-1119. 2010.</p>
<p>Neuhaus, J., Jacobs, D.R., Baker, J.V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L., Pett, S.L., Ristola, M., <strong><span style="text-decoration: underline;">Ross, M.J.</span></strong>, Shlipak, M., Tracy, R., and Neaton, J.D. Markers of Inflammation, Coagulation and Renal Function Are Elevated in Adults with HIV Infection. <em>J Infect Dis</em>. 201:1788-1795. 2010.</p>
<p>Chen, P., Chen, B.K., Mosoian, A., Hays, T., <strong><span style="text-decoration: underline;">Ross, M.J</span></strong>., Klotman, P.E., and Klotman, M.E. Virological Synapses Allow HIV-1 Uptake and Gene Expression in Renal Tubular Epithelial Cells. J Am Soc Nephrol. &nbsp;22(3): 496-507. 2011.</p>
<p>Leventhal, J.S., Alsauskas, Z., Snyder, A., Gong, P., Wang, B., D&rsquo;Agati, V., and <strong><span style="text-decoration: underline;">Ross, M.J.</span></strong> Renal HIV Expression Is Unaffected by Serum LPS Levels in an HIV Transgenic Mouse Model of LPS Induced Kidney Injury. <em>PLoS One.</em> <strong>6</strong>:e20688. 2011.</p>
<p>Papeta, N., Kiryluk, K., Patel, A., Sterken, R., Kacak, N., Snyder, H.J., Imus, P.H., Mhatre, A.N., Lawani, A.K., Julian, B.A., Wyatt, R.J., Novak, J., Wyatt, C.M., <strong><span style="text-decoration: underline;">Ross, M.J.</span></strong>, Winston, J.A., Klotman, M.E., Cohen, D.J., Appel, G.B., D&rsquo;Agati, V.D., Klotman, P.E., and Gharavi, A.G. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. <em>J Am Soc Nephrol.</em> 22:1991-1996. 2011.</p>
<p>Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>*, Wyatt CM*: Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults. PLoS ONE 7:e40245, (*co-senior authors). 2012.</p>
<p>Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD: Exposure to Antiretrovirals (ARVs) and Risk of Renal Impairment among HIV-positive Persons with Normal Baseline Renal Function: the D:A:D study. J Infect Dis 2013.</p>
<p>Ganesan A, Krantz EM, Huppler Hullsiek K, Riddle MS, Weintrob AC, Lalani T, Okulicz JF, Landrum M, Agan B, Whitman TJ, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Crum-Cianflone NF: Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care. HIV Med 14:65-76, 2013</p>
<p>Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis. 1;207(9):1359-69. 2013.</p>
<p>Lucas, G., Cozzi-Lepri, A., Wyatt, C., Post, F., Bormann, A., Crum-Cianflone, N., and <strong><span style="text-decoration: underline;">Ross, M</span></strong>. Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. HIV Med 15:116-123. PubMed PMID: 24024499. 2014.</p>
<p>Lucas, GM, <strong><span style="text-decoration: underline;">Ross, MJ</span></strong>, Stock, PG, Shlipak, MG, Wyatt, CM, Gupta, SK, Atta, MG, Wools-Kaloustian, KK, Pham, PA, Bruggeman, LA, Lennox, JL, Ray, PE, and Kalayjian, RC. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update By the HIV Medicine Association of the Infectious Diseases Society of America. <em>Clin Infect Dis</em>; 59(9), e96-e138. 2014.</p>
<p>Ryom, L., Mocroft, A., Kirk, O., <strong><span style="text-decoration: underline;">Ross, M</span></strong>., Reiss, P., Fux, C. A., Morlat, P., Moranne, O., Smith, C., El-Sadr, W., Law, M., and Lundgren, J. D. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. AIDS 28, 187-199. 2014.</p>
<p>Mocroft A, Lundgren J, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L; Data on Adverse Events&nbsp; (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT study&nbsp; group. A clinically useful risk-score for chronic kidney disease in HIV infection. J Int AIDS Soc ;17(4 Suppl 3):19514.. PMID: 25394023; PMCID: PMC4224906. 2014.</p>
<p>Leventhal, J.S., He, J.C., and <strong><span style="text-decoration: underline;">Ross, M.J</span></strong><span style="text-decoration: underline;">.</span> Autophagy and Immune Response in Kidneys. <em>Semin Nephrol.</em> 34(1):53-61. 2014.</p>
<p><strong><span style="text-decoration: underline;">Ross, M. J.</span></strong> (2014). Advances in the pathogenesis of HIV-associated kidney diseases. <em>Kidney Int.</em> 86, 266-274. 2014.</p>
<p>Mocroft A, Lundgren JD, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015 Mar 31;12(3):e1001809. PMID: 25826420; PMCID: PMC4380415. 2015.</p>
<p>Wolf T, <strong><span style="text-decoration: underline;">Ross MJ*</span></strong>, and Davenport A. Minimizing risks associated with renal replacement therapy in patients with Ebola Virus Disease. <em>Kidney Int.</em> 2015. 87, 5-7. 2015.</p>
<p>Achhra AC, Mocroft A, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Ryom L, Lucas GM, Furrer H, Neuhaus J, Somboonwit C, Kelly M, Gatell JM, Wyatt CM; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group. Kidney disease in antiretroviral-na&iuml;ve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med;16 Suppl 1:55-63. PMID: 25711324; PMCID: PMC4341947. 2015.</p>
<p>Mocroft A, Lundgren JD, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. Lancet HIV. 3:e23-32. 2016.</p>
<p>Leventhal JS, Ni J, Osmond M, Lee K, Gusella GL, Salem F, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>. Autophagy Limits Endotoxemic Acute Kidney Injury and Alters Renal Tubular Epithelial Cell Cytokine Expression. PLoS One. 11(3):e0150001. 2016.</p>
<p>Ryom, L, Lundgren, JD, <strong><span style="text-decoration: underline;">Ross, M</span></strong>, Kirk, O, Law, M, Morlat, P, Smit, C, Fontas, E, Fux, CA, Hatleberg, CI, de Wit, S, Sabin, CA, Mocroft, A, D:A:D, SG. Renal Impairment and Cardiovascular Disease in HIV-positive Individuals; The D:A:D Study. J Infect Dis. PMID: 27485357. 2016.</p>
<p>Ryom L, Mocroft A, Kirk O, Reiss P, <strong><span style="text-decoration: underline;">Ross M,</span></strong> Smith C, Moranne O, Morlat P, Fux CA, Sabin C, Phillips A, Law M, Lundgren JD; D:A:D study group.. Predictors of eGFR progression, stabilisation or improvement after chronic renal impairment in HIV-positive individuals. AIDS. 2017 Mar 28. PMID: 28353536.</p>
<p>Nadkarni GN, Wyatt CM, Murphy B, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>. APOL1: a case in point for replacing race with genetics. Kidney Int. 2017 Apr;91(4):768-770. PMID: 28314574.</p>
<p>Rednor SJ, <strong>Ross MJ</strong>. Molecular Mechanisms of Injury in HIV-Associated Nephropathy. Front Med (Lausanne). 2018; 5:177. PMID: 29930940 PMCID: PMC5999756</p>
<p><strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Coates PT. Using CRISPR to inactivate endogenous retroviruses in pigs: an important step toward safe xenotransplantation. Kidney Int. 2018; 93:4-6, PMID: 29198467.</p>
<p><strong><span style="text-decoration: underline;">Ross MJ.</span></strong> New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease. Kidney Int Rep. 2019; 4:908-910 PMC6611947.</p>
<p>Ryom L, Dilling Lundgren J, Reiss P, Kirk O, Law M, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Morlat P, Andreas Fux C, Fontas E, De Wit S, D'Arminio Monforte A, El-Sadr W, Phillips A, Ingrid Hatleberg C, Sabin C, Mocroft A. Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. J Infect Dis. 2019 Oct 8;220(10):1629-1634. doi: 10.1093/infdis/jiz369. PubMed PMID: 31504669; PubMed Central PMCID: PMC6782100.</p>
<p>Gao X, Rosales A, Karttunen H, Bommana GM, Tandoh B, Yi Z, Habib Z, Agati V, Zhang W, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>. The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms. Sci Rep. 2019 Nov 1;9(1):15857. doi: 10.1038/s41598-019-52278-3. PubMed PMID: 31676833; PubMed Central PMCID: PMC6825220.</p>
<p>Townsend RR, Guarnieri P, Argyropoulos C, Blady S, Boustany-Kari CM, Devalaraja-Narashimha K, Morton L, Mottl AK, Patel U, Palmer M, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Sarov-Blat L, Steinbugler K, Susztak K. Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Kidney Int. 2020 Jan;97(1):10-13. doi: 10.1016/j.kint.2019.09.020. PubMed PMID: 31901339.</p>
<div class="citation-text" data-citation-style="ama">Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, <strong><span style="text-decoration: underline;">Ross M,</span></strong> Forest S, Goldstein YD, Ajaimy M, Liriano-Ward L, Pynadath C, Loarte-Campos P, Nandigam PB, Graham J, Le M, Rocca J, Kinkhabwala M. Covid-19 and Kidney Transplantation. N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24. PMID: 32329975; PMCID: PMC7200055.</div>

EMR ID

1540

Biography

<p>Dr. Michael Ross received his MD degree at NYU and completed internal medicine residency training at Duke University, followed by Nephrology Fellowship training at the Icahn School of Medicine at Mount Sinai. While he was on the faculty in the Mount Sinai Division of Nephrology from 2001-17, he served as Nephrology Fellowship Program Director from 2004-2015. He became Chief of Nephrology at the James J. Peters VA Medical Center from 2014-2017, where he helped establish the only VA Kidney Transplant Program in the northeastern US. Dr. Ross became Chief of the Division of Nephrology at the Albert Einstein College of Medicine/Montefiore Medical Center in 2017 where he is currently Chief of Nephrology and Professor of Medicine and Developmental and Molecular Biology.&nbsp;</p><p>Dr. Ross has served in several national/international leadership roles for the American Society of Nephrology and other organizations, served as Deputy Editor of Kidney International, and is currently Nephrology Section Editor of the American College of Physicians Medical Knowledge and Self-Assessment Program. Dr. Ross was also the recipient of the 2021 American Society of Nephrology Distinguished Leader Award. The major focus of Dr. Ross&rsquo; research program is to identify novel mechanisms of HIV-induced kidney diseases and other forms of kidney injury. He is also site principal investigator of clinical and translational research studies of diabetic kidney disease and other kidney diseases.&nbsp;<br /></p>

Is Open Scheduling

Off

Kimberly J. Reidy

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/3968bb50-3ab5-11ed-8158-59ecbd24247c.jpg

First Name

Kimberly

Last Name

Reidy

NPI

1760652556

Faculty ID

10200

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

4390

Biography

<p>Kimberly J. Reidy, MD, is Chief, Division of Pediatric Nephrology and Associate Professor at Children&rsquo;s Hospital at Montefiore (CHAM) and Montefiore Einstein. Her clinical focus is on the treatment of hypertension and childhood-onset kidney disease. She has particular interest in nephrotic syndrome and glomerular diseases, congenital abnormalities of the kidney and urinary tract, and genetic kidney diseases.</p><p>After earning her Bachelor of Arts in chemistry at Princeton University in 1997, Dr. Reidy attended Albert Einstein College of Medicine, earning her Doctor of Medicine in 2002. Her postdoctoral training began with a pediatric internship and residency at Children&rsquo;s Hospital of New York, NewYork-Presbyterian from 2002 to 2005. She then pursued a three-year National Institutes of Health (NIH) supported fellowship in pediatric nephrology at CHAM, completing it in 2008.</p><p>Dr. Reidy&rsquo;s clinical research focuses on children with glomerular and chronic kidney disease, including NIH funded Nephrotic Syndrome Study Network (NEPTUNE) and Cure Glomerulonephropathy (CureGN) studies of children with nephrotic syndrome. Her translational research focuses on the effect of APOL1 risk variants on preeclampsia and perinatal outcomes. Her bench research focuses on effects of developmental genes on kidney repair and fibrosis after injury. She has shared her work through many peer-reviewed journals, invited presentations, book chapters and abstracts. Dr. Reidy is also an ad hoc reviewer for many journals including <em>Pediatric Nephrology, Kidney International and the Journal of the American Society of Nephrology</em>.</p><p>Dr. Reidy is board-certified in pediatrics and pediatric nephrology. She is an active member of several professional organizations including the American Society of Pediatric Nephrology, the American Academy of Pediatrics (AAP) and the Neonatal Kidney Collaborative. She currently serves on the Executive Committee of the Section of Nephrology for the AAP. From 2016 through 2021, she has been listed among Castle Connolly Top Doctors: New York Metro Area. In 2021, she was elected to membership in the Leo M. Davidoff Society, recognizing her long-term commitment to excellence in teaching medical students.</p>

Is Open Scheduling

Off

Amanda C. Raff

https://assets.montefioreeinstein.org/profiles/images/amanda-raff.jpg

First Name

Amanda

Last Name

Raff

NPI

1952490369

Faculty ID

8749

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">Dr. Raff is a Professor of Medicine and the Associate Chair of Medicine for Undergraduate Medical Education. She has been the Course Director for the Einstein first year medical student Renal System Course since 2007 and the Internal Medicine Clerkship and Acting Internship Director since 2012.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">She a faculty mentor for the student led Step 1 Group near-peer evidence based guidance program and the Internal Medicine Interest Group.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">She has a clinical practice of CKD and ESRD patients and enjoys rounding on the inpatient Renal Consult and Dialysis services.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">Dr. Raff&rsquo;s contributions in the field of Medical Education include serving as a Case Editor for&nbsp;&nbsp;Aquifer Internal Medicine, contributing author and reviewer for the Clerkship Directors in Internal Medicine (CDIM) curriculum revision and MKSAP 19 Nephrology section committee member.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">She has been recognized for her teaching excellence at Einstein with the Samuel M. Rosen Outstanding Teacher Award for Excellence in Basic Science Teaching, the Harry Eagle Award for Outstanding Basic Science Teaching, the Harry H. Gordon Award for Outstanding Clinical Teaching and membership in the Leo M. Davidoff Society.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">Dr. Raff received a bachelor's degree in biology from Indiana University and a MD from Albert Einstein College of Medicine. She completed a residency in Internal Medicine at NewYork Presbyterian Hospital and a chief resident year at NYU Downtown Hospital. She returned to Einstein/Montefiore for a Nephrology Fellowship and joined the Einstein Division of Nephrology faculty in 2004.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Autosomal Dominant Polycystic Kidney Disease (ADPKD)<br />Chronic Kidney Disease (CKD)<br />End Stage Kidney Disease (ESKD, ESRD)<br />Acute Kidney Injury (AKI)<br />Glomerular diseases<br />Hypertension<br />Electrolyte Disorders<br />Kidney Stones<br />

Research Focus

<p><span style="color:black;">&nbsp;</span></p>

Elsevier Profile

Selected Publications

<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">1.&nbsp;</span><span style="font-size: 12pt; font-family: Cambria; color: #212121;">Fitz M, Adams W, Haist S, Hauer K, Ross P,&nbsp;<strong>Raff A</strong>, Agarwal G, Vu T, Appelbaum J, Lang V, Miller C, Grum C and the Clerkship Directors in Internal Medicine &ndash; National Board of Medical Examiners EXPRESS Study Group. Which Internal Medicine Clerkship Characteristics Are Associated With Students' Performance on the NBME Medicine Subject Exam? A Multi-Institutional Analysis.&nbsp;<em>Acad Med</em>. 2020;10.1097/ACM.0000000000003322 [published online ahead of print, 2020 Mar 17].&nbsp;</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria; color: #212121;">2.&nbsp;</span><span style="font-size: 12pt; font-family: Cambria;">Brien K (Author), Calvo L (Associate editor),&nbsp;<strong>Raff A</strong>&nbsp;(Case editor).&nbsp;<em>Aquifer Internal Medicine Case 33: 49-year-old woman with confusion</em>. 2019&nbsp;</span><u><span style="font-size: 12pt; font-family: Cambria; color: #3366ff;">https://www.aquifer.org</span></u></p&gt;
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria; color: #212121;">3.&nbsp;</span><span style="font-size: 12pt; font-family: Cambria;">Khan M, Gil N, Lin W, Fiter R, Kenawy D, Burton W,&nbsp;<strong>Raff A</strong>.&nbsp;&nbsp;The impact of Step 1 scores on medical students&rsquo; residency specialty choice.&nbsp;<em>Med Sci Educ.</em>&nbsp;28(4): 699-705. 2018.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">4.&nbsp;Ludwig A,&nbsp;<strong>Raff A</strong>, Lin J, Schoenbaum E. Group Observed Structured Encounter (GOSCE) for third year medical students improves self-assessment of clinical communication.&nbsp;<em>Medical Teacher</em>&nbsp;39(9): 931-5.&nbsp;2017.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">5.&nbsp;Golestaneh L, Neugarten J, Southern W, Kargoli F,&nbsp;<strong>Raff A</strong>.&nbsp;&nbsp;Improving the diagnostic workup of hyponatremia in the setting of kidney disease: a continuing medical education (CME) initiative.&nbsp;<em>Int Urol Nephrol</em>&nbsp;49(3): 491-7. 2017</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">6.&nbsp;Czapka M,&nbsp;<strong>Raff A</strong>, Risley M.&nbsp;&nbsp;Safe Transitions: An active learning module for discharge summaries and interprofessional care.&nbsp;<em>MedEdPORTAL&nbsp;iCollaborative</em>. 2017</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">7.&nbsp;Tanenbaum, E, Johnson J, Jordan, E, Cottral J, Tenore C, Burton W, McGinn A<strong>, Raff A</strong>.&nbsp;&nbsp;An effective evidence-based student run near-peer support group for the USMLE Step 1 Exam.&nbsp;&nbsp;<em>Med Sci Educ</em>. 26(4): 691-9. 2016</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">8.&nbsp;Ludwig A, Lee R, Parish S,&nbsp;<strong>Raff A</strong>. Four-station group observed structured clinical encounter for formative assessment of communication skills for internal medicine clerks.&nbsp;<em>MedEdPORTAL Publications</em>. 12:10444. 2016&nbsp;</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">9.&nbsp;Chen W, Melamed M, Hostetter T, Bauer C,&nbsp;<strong>Raff A</strong>, Almudevar A, Lalonde A, Messing S, Abramowitz M.&nbsp;&nbsp;Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study.&nbsp;&nbsp;<em>BMC Nephrol</em>. 17(1): 114. doi: 10.1186/s12882-016-0331-6. 2016</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">10.&nbsp;Jion Y,&nbsp;<strong>Raff A</strong>, Grosberg B, Evans R.&nbsp;&nbsp;The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension.&nbsp;&nbsp;<em>Headache</em>. 55(1): 161-6. 2015</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">11. Jion Y,&nbsp;<strong>Raff A</strong>, Grosberg B, Evans R.&nbsp;&nbsp;Topiramate and nephrolithiasis: a response.&nbsp;&nbsp;<em>Headache</em>. 55(5): 710-2. 2015</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">12.&nbsp;Abramowitz, M, Melamed M, Bauer C,&nbsp;<strong>Raff A</strong>, Hostetter T.&nbsp;&nbsp;Effects of oral sodium bicarbonate in patients with CKD.&nbsp;&nbsp;<em>Clin J Am Soc Nephrol</em>. 8(5): 714-20. 2013</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">13. Berman N, Lectura M, Thurman J, Reinecke J,&nbsp;<strong>Raff A</strong>, Melamed M, Quan Z, Evans T, Meyer T, Hostetter T.&nbsp;&nbsp;A zebrafish model for uremic toxicity: role of the complement pathway.&nbsp;&nbsp;<em>Blood Purif</em>. 35(4): 265-9. 2013</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">14.&nbsp;Bomback A,&nbsp;<strong>Raff A</strong>.&nbsp;&nbsp;Olfactory function in dialysis patients: a potential key to understanding the uremic state.&nbsp;&nbsp;<em>Kidney Int</em>.&nbsp;&nbsp;80(8): 803-5.&nbsp;&nbsp;2011</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">15.&nbsp;Ponda M, Quan Z, Melamed M,&nbsp;<strong>Raff A</strong>, Meyer T, Hostetter T.&nbsp;&nbsp;&nbsp;Methylamine clearance by haemodialysis is low.&nbsp;&nbsp;<em>Nephrol Dial Transplant</em>.&nbsp;&nbsp;25(5): 1608-13. 2010</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">16.&nbsp;<strong>Raff A</strong>,&nbsp;&nbsp;Lieu S, Melamed M, Quan Z, Ponda M, Meyer T, Hostetter T.&nbsp;&nbsp;Relationship of Impaired Olfactory Function in ESRD to Malnutrition and Retained Uremic Molecules.&nbsp;<em>Am J Kidney Dis</em>.&nbsp;&nbsp;52(1): 102-10.&nbsp;&nbsp;2008</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">17.&nbsp;<strong>Raff A</strong>, Meyer T, Hostetter T.&nbsp;&nbsp;New Insights into uremic toxicity.&nbsp;&nbsp;<em>Curr Opin Nephrol Hypertens</em>.&nbsp;&nbsp;17(6): 560-5.&nbsp;&nbsp;2008</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">18.&nbsp;Susztak K,&nbsp;<strong>Raff A</strong>, Schiffer M, Bottinger E.&nbsp;&nbsp;Glucose &ndash; induced&nbsp;&nbsp;&nbsp;reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.&nbsp;<em>Diabetes</em>. 55(1): 225-33.&nbsp;&nbsp;2006</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">19.&nbsp;Schiffer M. Susztak K, Ranalletta M,&nbsp;<strong>Raff A</strong>, Bottinger E, Charron M.&nbsp;&nbsp;Localization of the GLUT8 transporter in murine kidney and regulation in vivo in non-diabetic and diabetic conditions.&nbsp;&nbsp;<em>Am J Physiol Renal Physiol</em>, 289(1): F186-193.&nbsp;&nbsp;2005</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">20.&nbsp;<strong>Raff A</strong>, Hebert T, Pullman J, Coco M.&nbsp;&nbsp;Crescentic post-streptococcal glomerulonephritis with nephrotic syndrome in the adult: is aggressive therapy warranted?&nbsp;&nbsp;<em>Clinical Nephrology</em>, 63(5): 375-380.&nbsp;&nbsp;2005</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">21.&nbsp;Spector M,&nbsp;<strong>Raff A</strong>, DeSilva H, Lee K, Osley M.&nbsp;&nbsp;Hir1p and Hir2p function as transcriptional corepressors to regulate histone gene transcription in&nbsp;<em>Saccharomyces cerevisiae&nbsp;</em>cell cycle.&nbsp;<em>&nbsp;Molecular and Cellular Biology</em>, 17(2):&nbsp;&nbsp;545-552.&nbsp;&nbsp;1997</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">22.&nbsp;Recht J, Dunn B,&nbsp;<strong>Raff A</strong>, Osley M.&nbsp;&nbsp;Functional analysis of histone H2A and H2B in transcriptional repression in&nbsp;<em>Saccharomyces cerevisiae. Molecular and Cellular Biology</em>, 16(6):&nbsp;&nbsp;2545-2553<em>.</em>&nbsp;&nbsp;1996</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">23.&nbsp;Kopczynski J,&nbsp;<strong>Raff A</strong>, Bonner J.&nbsp;&nbsp;Translational readthrough at nonsense mutations in the&nbsp;<em>HSF1</em>&nbsp;gene of&nbsp;<em>Saccharomyces cerevisiae.&nbsp;</em>&nbsp;<em>Molecular and General Genetics</em>, 234: 369-378.&nbsp;&nbsp;1992</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: 'Times New Roman';">&nbsp;</span></p>

EMR ID

4469

Biography

<p>Amanda C. Raff, MD, is Attending Physician, Professor and Associate Chair of Medicine for Undergraduate Medical Education at Montefiore-Einstein. She is also the co-director of the Montefiore-Einstein Autosomal Dominant Polycystic Kidney Disease Program. Dr. Raff&rsquo;s clinical focus is on dialysis and the treatment of patients with chronic kidney disease and end stage kidney disease.</p><p>After earning her Bachelor of Science in biology at Indiana University, Dr. Raff completed her Doctor of Medicine at Albert Einstein College of Medicine, earning her degree in 1998.&nbsp; Her postdoctoral training began at New York Presbyterian Hospital with an internship and residency in internal medicine from 1998 through 2001. She was assistant chief resident at Memorial Sloan Kettering Cancer Center in 2000 and chief resident at New York University Downtown Hospital from 2001 to 2002. She then returned to Montefiore-Einstein to complete a two-year fellowship in nephrology in 2004.</p><p>Dr. Raff&rsquo;s research focuses on medical education. She has been the Course Director for the Einstein medical student Renal Course since 2007 and the Internal Medicine Clerkship and Acting Internship Director since 2012. Dr. Raff&rsquo;s contributions in the field of Medical Education include serving as a Nephrology section committee member for the American College of Physicians&rsquo; Medical Knowledge Self-Assessment Program (MKSAP) 19 and 20 as well as prior work as a Case Editor for Aquifer Internal Medicine and contributing author and reviewer for the Clerkship Directors in Internal Medicine (CDIM) curriculum revision.</p><p>An enthusiastic medical educator, Dr. Raff has received several awards for her teaching and in 2010 was inducted into the Leo M. Davidoff Society for outstanding achievement in the teaching of medical students. She is board certified and is a member the American Society of Nephrology and a fellow of the American College of Physicians.</p>

Visit Type ID

2541

Is Open Scheduling

On

Joel Neugarten

https://assets.montefioreeinstein.org/profiles/images/physphoto/Neugarten_Joel_MD_420x504.jpg

First Name

Joel

Last Name

Neugarten

NPI

1750466520

Faculty ID

1225

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Acute and Chronic Kidney Disease<span style="font-size:10.5pt;font-family:'Arial',sans-serif;color:#5B5B5B;"></span></p>

Research Focus

Dr. Neugarten's main research interest is investigating mechanisms of acute and chronic kidney injury

Elsevier Profile

Selected Publications

<p><ol>
<li>Neugarten J. Estrogen and oxidative stress. Gend Med. Mar;4(1):31-2. 2007.</li>
<li>Silbiger S, Neugarten J. Gender and human renal disease. Gend Med.5: Suppl A:S3-S10. Review</li>
<li>Neugarten J: Estrogen and reactive oxygen species. Gender Med. . 2008</li>
</ol></p>

EMR ID

3415

Biography

Dr. Joel Neugarten is currently Professor of Medicine at the Albert Einstein College of Medicine, Medical Director of the Bedford Park Dialysis Unit, and an Attending Nephrologist at Montefiore Medical Center in the Bronx, New York. He is a graduate of the Albert Einstein College of Medicine and the Brooklyn Law School and completed his post graduate training at Mount Sinai Medical Center in New York and at New York University Medical Center. He previously served as Site Director of the Nephrology Division of Montefiore Medical Center and as President of the New York Society of Nephrology. He is an author of over 100 peer reviewed publications and book chapters dealing with numerous aspects of Nephrology. His major research interests include factors that influence the progression of chronic kidney disease and the management of patients with chronic kidney disease.

Visit Type ID

2541

Is Open Scheduling

On

Tina M. Neade

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/7bb3fcb0-c3cc-11eb-9ea2-7374238588d1.jpg

First Name

Tina

Last Name

Neade

NPI

1538331061

Faculty ID

16814

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic kidney disease, Glomerular disease, End stage renal disease, Kidney stones and Hypertension

Elsevier Profile

EMR ID

52322

Biography

Tina Neade, M.D., is an Assistant Professor of Medicine in the Division of Nephrology at Montefiore Medical Center/ Albert Einstein College of Medicine. She earned her medical degree at Albert Einstein College of Medicine, New York in 2002. She then completed her internal medicine residency at Mount Sinai Hospital in New York in 2005, followed by a nephrology fellowship at Mount Sinai Hospital in 2008. Dr Neade joined the faculty at Montefiore Medical Center in 2017. Dr. Neade is board certified in Internal Medicine and Nephrology.&nbsp;

Visit Type ID

2541

Is Open Scheduling

On

Michal L. Melamed

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/66412790-2b53-11ee-9f8d-1b267177a44e.jpg

First Name

Michal

Last Name

Melamed

NPI

1407953235

Faculty ID

10492

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Michal Melamed is a Professor of Medicine and Epidemiology &amp; Population Health at the Albert Einstein College of Medicine. She has been the Nephrology Fellowship Program Director since 2012. After completing her undergraduate degree in Dramatic Literature at New York University <em>summa cum laude</em>, she trained at Johns Hopkins School of Medicine for medical school, Internal Medicine residency, and Nephrology fellowship. Additionally, she completed a Masters in Clinical Epidemiology from the Johns Hopkins Bloomberg School of Public Health during her fellowship.</p>
<p>She has been continuously funded by the National Institutes of Health since 2007 and her research interests include the epidemiology of chronic kidney disease and its complications, the epidemiology and health consequences of Vitamin D deficiency and metabolic acidosis. Dr. Melamed is the Principal Investigator of several NIH-funded research studies.&nbsp; She has published over 90 original publications in the medical literature and has mentored countless young investigators from high school students to junior faculty members. In 2019, she won the Distinguished Mentor Award from the American Society of Nephrology.</p>
<p>&nbsp;</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>Selected Publications:<br />&nbsp;<br /><strong>Melamed ML</strong>, Eustace JA, Plantinga L, Jaar BG, Fink NE, Klag MJ, Coresh J, Powe NR. Changes in Serum Calcium, Phosphate and PTH and the Risk of Death in Incident Dialysis Patients: A Longitudinal Study. Kidney Int 2006 Jul;70(2):351-7.<br />&nbsp;<br />Gupta R, Plantinga LC, Fink NE, <strong>Melamed ML</strong>, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007 Apr 4;297(13):1455-64.<br />&nbsp;<br />Hailpern SM, <strong>Melamed ML</strong>, Cohen HW, Hostetter T.&nbsp; Moderate Chronic Kidney Disease and Cognitive Function in Adults 20-59 Years of Age (NHANES III). J Am Soc Nephrol 2007 Jul;18(7):2205-13.<br />&nbsp;<br /><strong>Melamed ML,</strong> Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR. Third-Generation Parathyroid Hormone Assays and All-Cause Mortality in Incident Dialysis Patients: The CHOICE Study. Nephrol Dial Transplant. 2008 May; 23(5):1650-8.</p>
<p><strong>Melamed ML*, </strong>Muntner P*, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P. Serum 25-hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001-2004. Atheroscler Thromb Vasc Biol. 2008 Jun;28(6)1179-85.<br />&nbsp;<br /><strong>Melamed ML*, </strong>Michos ED*, Post W, Astor B. 25-Hydroxyl Vitamin D Levels and the Risk of Mortality in the General Population. Arch Intern Med. 2008 Aug 11;168(15):1629-37.<br />&nbsp;<br />Shah S, Abramowitz M, Hostetter TH, <strong>Melamed ML</strong>. Serum Bicarbonate Levels and the Progression of Kidney Disease: A Cohort Study. Am J Kidney Dis. 2009 Aug;54(2):270-7.<br />&nbsp;<br />Kumar J, Muntner P, Kaskel FJ, Hailpern SM, <strong>Melamed ML</strong>. Prevalence and Associations of 25- Hydroxyvitamin D Deficiency in Children and Adolescents in the United States: Results from NHANES 2001-2004. Pediatrics. Aug 3 2009. Electronic pages.<br />&nbsp;<br />Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, <strong>Melamed ML</strong>, Powe NR, Jaar BG. Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis. Clin J Am Soc Nephrol. 2009 Oct;4 (10):1637-45.<br />&nbsp;<br />Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, <strong>Melamed ML</strong>, Wiebe N, Muntner P. Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality. Circulation. 2009 Oct. 19 Epub. 2009 Nov 3;120(18):1784-92.<br />&nbsp;<br /><strong>Melamed ML</strong>, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-Hydroxyvitamin D levels, Race and the Progression of Kidney Disease. J Am Soc Nephrol. 2009 Dec.;20(12) 2631-9.<br />&nbsp;<br />Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, Hostetter TH, <strong>Melamed ML</strong>. Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol. 2010 Apr 8 Epub. 2010 Jun;5(6):1064-71.<br />&nbsp;<br />Murea M, Park JK, Sharma S, Kato H, Gruenwald A, Niranjan T, Si H, Thomas DB, Pullman JM, <strong>Melamed ML</strong>, Susztak K. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int. 2010 June 9; 78(5):514-22.<br />&nbsp;<br /><strong>Melamed ML, </strong>Blackwell T, Neugarten J, Arnsten J, Ensrud K, Ishani A, Cummings S, Silbiger S. Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int. 2011 Jan;79(2):241-9<br /><strong>&nbsp;</strong><br />O&rsquo; Seaghdha CM, Hwang S-J, Muntner P, <strong>Melamed ML</strong>*, Fox CS*. Serum phosphorus predicts incident Chronic Kidney Disease and End-Stage Renal Disease. Nephrol Dial Transplant 2011 Sep;26(9):2885-90. Epub 2011 Feb 3.<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Association of Serum Bicarbonate Levels with Gait Speed and Quadriceps Strength in Older Adults. Am J Kidney Dis 2011 Feb 25.<br />&nbsp;<br />Sharief S, Jariwala S, Kumar J, Muntner P, <strong>Melamed ML</strong>. Vitamin D levels and food and environmental allergies in the United States: Results from NHANES 2005-6. Journal of Allergy and Clinical Immunology 2011 May;127(5):1195-202. Epub 2011 Feb 16. PMID: 21329969<br />&nbsp;<br />Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, <strong>Melamed ML</strong>. Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab. 2011 Sept 28. (Epub)<br />&nbsp;<br />Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharrett AR, <strong>Melamed ML</strong>. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES III linked mortality files. Nutrition 2012 Apr; 28(4)367-71.<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults. Kidney International. 2012 May;81(10):103342. Epub 2012 Feb 1. PMCID: PMC3340439<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. The serum anion gap is altered in early kidney disease and associates with mortality. Kidney International. 2012 Sep;82 (6):701-9.<br />&nbsp;<br />Abramowitz MK, <strong>Melamed ML</strong>, Bauer C, Raff AC, Hostetter TH. Effects of Oral Sodium Bicarbonate in Patients with CKD. Clinical Journal of the American Society of Nephrology. 2013 Feb 7^th Epub ahead of print. 2013 May; 8(5)714-20.<br /><br /><strong>Melamed ML</strong>, Plantinga L, Shafi T, Parekh R, Meyer TW, Hostetter TH, Coresh J, Powe NR. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol 2013 June 27;14(1)134.<br />&nbsp;<br />Milman S, Schulder-Katz M, Deluty J, Zimmerman ME, Crandall JP, Barzilai N, <strong>Melamed ML*</strong>, Atzmon G*.&nbsp; Individuals with Exceptional Longevity Manifest a Delayed Association Between Vitamin D Insufficiency and Cognitive Impairment. J Am Geriatr Soc. 2014 Jan Epub.<br />&nbsp;<br />Akchurin OM, <strong>Melamed ML</strong>, Hashim BL, Kaskel FJ, Del Rio M. Medication adherence in the transition of adolescent kidney transplant recipients to the adult care. Pediatric Transplantation. 2014 May 12 Epub. 18(5):538-48.<br />&nbsp;<br />Chen W, <strong>Melamed ML</strong>, Abramowitz MK. Serum bicarbonate and Bone Mineral Density in US Adults. Am J Kidney Dis. 2014 Aug 26 Epub. 2015 Feb;65(2):240-8.&nbsp;<br />&nbsp;<br />Sarathy H, Pramanik V, Kahn J, Abramowitz MK, Meier K, Kishore P, <strong>Melamed ML</strong>. The Effects of Short-term Vitamin D Supplementation on Glucose Metabolism in Dialysis Patients: A Systematic Review and Meta-Analysis.&nbsp; Int Urol Nephrol. 2015 Mar;47(3):537-49.&nbsp;<br />&nbsp;<br />Barry EL, Mott LA, <strong>Melamed ML,</strong> Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One. 2014. Oct 15;9(10):e108094.<br />&nbsp;<br />Calp-Inal S, Ajaimy M, <strong>Melamed ML</strong>, Savchik C, Masiakos P, Colovai A, Akalin E. The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation.&nbsp; Kidney Int 2015 Nov 4 (Epub ahead of print)<br />&nbsp;<br />Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, Furth SL, Warady BA, Portale AA, <strong>Melamed ML. </strong>Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKID) cohort. Pediatr Nephrol. 2016 Jan; 31(1):121-9.</p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-no-proof: yes;">Chen W, <strong>Melamed ML</strong>, Hostetter TH, Bauer C, Raff AC, Almudevar AL, Lalonde A, Messing S, Abramowitz MK. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study. <em>BMC Nephrol. </em>2016;17(1):114.</span></p>
<p><span style="text-indent: -0.25in; font-size: 11pt; font-family: Arial, sans-serif;">Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, <strong>Melamed ML</strong>, Banerjee T, Coresh J, Hostetter TH. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. <em>J Am Soc Nephrol. </em>2017 Jan;28(1):321-31.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Goel N, Kwon C, Zachariah TP, Broker M, Folkert VW, Bauer C, <strong>Melamed ML</strong>. Vascular access placement in patients with chronic kidney disease stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.&nbsp; <em>BMC Nephrol</em>. 2017; 18(1):28.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Buttar RS, Batra J, Kreimerman J, Aleta M, <strong>Melamed ML</strong>. Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels. J Gen Intern Med. 2017 Oct;32(10):1156-1159.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Golestaneh L Bellin E, Southern W, <strong>Melamed ML</strong>. Discharge service as a determinant of 30-day readmission in a cohort of maintenance hemodialysis patients: a retrospective cohort study. BMC Nephrol. 2017 Dec 4;18(1):352.</span></p>
<p><strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Melamed ML</span></strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">, Chonchol M, Gutierrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018; 72(6)834-845.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Astor BC, Djamali A, Mandelbrot DA, Parajuli S, <strong>Melamed ML</strong>. The Association of 25-hydroxyvitamin D Levels with Late Cytomegalovirus Infection in Kidney Transplant Recipients: the Wisconsin Allograft Recipient Database (WisARD). Transplantation</span> <span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2019 Aug;103(8):1683-1688</span></p>
<p><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Chen W, Eisenberg R, Mowrey WB, Wylie-Rosett J, Abramowitz MK, Bushinsky DA, <strong>Melamed ML</strong>.&nbsp; Association between dietary zinc intake and abdominal aortic calcification in US adults. Nephrol Dial Transplant. 2019 Jul 11.</span></span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Sochol KM, Johns TS, Buttar RS, Randhawa L, Sanchez E, Gal M, Lestrade K, Merzkani M, Abramowitz MK, Mossavar-Rahmani Y, </span><strong style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Melamed ML</strong><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">. The Effects of Dairy Intake on Insulin Resistance: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients 2019; 11(9):2237.</span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;"><strong>Melamed ML</strong>, Horwitz EJ, Dobre MA, Abramowitz MK, Zhang L, Lo Y, Mitch WE, Hostetter TH. The Effects of Sodium Bicarbonate in Chronic Kidney Disease Stages 3 and 4: A Randomized, Placebo-Control, Multi-Center Clinical Trial. American Journal of Kidney Diseases. 2020.</span></p>
<p>&nbsp;</p>

EMR ID

4836

Is Open Scheduling

Off

Neelja D. Kumar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f076dd00-43b4-11ee-a7f9-01ad5bafacad.jpg

First Name

Neelja

Last Name

Kumar

NPI

1396911236

Faculty ID

14242

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic Kidney Disease, Renal disease associated with pregnancy, diabetic kidney disease, acute kidney injury, hypertension

Research Focus

Clinical Nephrology and Education

Elsevier Profile

EMR ID

69712

Biography

Neelja Kumar, MD, earned her medical degree at Sophie Davis School of Biomedical Education with Stonybrook Medical Center, New York. She completed her clinical fellowship in Nephrology at Yale School of Medicine, New Haven Connecticut. Dr. Kumar completed her residency in internal medicine at New York University Langone Medical Center and then went on to complete an additional year as chief resident. Dr. Kumar is a board-certified nephrologist and has been part of the faculty at Montefiore since 2014. Dr. Kumar serves as Medical Director at an outpatient dialysis unit in the Bronx. Additionally, Dr. Kumar is an Associate Program Director for the nephrology fellowship program and has worked to enrich the academic curriculum for the clinical fellows. <span style="color:#000000;font-family:Inter, sans-serif;font-size:13.125px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:start;text-indent:0px;text-transform:none;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;white-space:pre-wrap;background-color:#f5f5f4;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;display:inline !important;float:none;">Her clinical interests within nephrology include renal disease in the critically ill population and renal disease during pregnancy.</span>

Visit Type ID

2541

Is Open Scheduling

On

Mahsa Kanzali

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Mahsa

Last Name

Kanzali

NPI

1295122661

Faculty ID

18306

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

76958

Is Open Scheduling

Off

Tanya S. Johns

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/346233f0-178e-11ee-be6e-3f9a8c4cef15.jpg

First Name

Tanya

Last Name

Johns

NPI

1699932095

Faculty ID

13910

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic Kidney Disease

Research Focus

Chronic Kidney Disease. Healthcare delivery models, Nutrition

Elsevier Profile

EMR ID

5759

Biography

Tanya Johns, MD, MHS is an Associate Professor of Medicine and a Clinical Investigator in the Department of Medicine/ Division of Nephrology at the Albert Einstein College of Medicine/ Montefiore Medical Center. Dr. Johns earned her medical degree from Weill Medical College of Cornell University and completed Internal Medicine training at NY Presbyterian, where she was also an Assistant Chief Resident. Dr. Johns graduated from the Johns Hopkins Nephrology Fellowship with a Masters in Health Sciences in Clinical Epidemiology. She specializes in care of patients with various kidney disorders and serves as the medical director for Montefiore&rsquo;s Kidney Care Program, an interdisciplinary care clinic for patients with chronic kidney disease. Dr. Johns is an NIH supported researcher and her over-arching research goal is to increase health equity and improve outcomes for all patients with kidney disease.&nbsp;

Visit Type ID

2541

Is Open Scheduling

On

Sonali Gupta

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/ad26aa20-5fbe-11ec-8136-139dc31b73e2.jpg

First Name

Sonali

Last Name

Gupta

NPI

1245683671

Faculty ID

17303

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic kidney disease, hypertension, renal diseases in pregnancy, glomerular disease

Research Focus

Renal diseases in pregnancy, hypertension, chronic kidney disease, medical education

Elsevier Profile

EMR ID

164238

Biography

<p>Sonali Gupta, M.D. completed her medical education at the Lady Hardinge Medical College, New Delhi, India, Residency in Obstetrics and Gynecology at Maulana Azad Medical College, New Delhi, India, followed by an additional year of research in maternal fetal medicine at the University of Tennessee Health Science Center, Memphis. She then completed internal medicine residency at St Vincent&rsquo;s Medical Center, Quinnipiac University Frank H. Netter MD School of Medicine followed by fellowship in nephrology at the University of Rochester and University of Iowa.</p><p>Dr. Gupta is the author of over 35 original articles and 3 book chapters. She has presented her work at various national and international meetings. Dr. Gupta is member of several societies including the American Society of Nephrology. Her clinical expertise is in the area of chronic kidney disease, obstetric nephrology and management of hypertension.<br /></p>

Visit Type ID

2541

Is Open Scheduling

On

Zocdoc Link